One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2018-99-113467
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 29, 2018 |
 Citations: 7 |
Affiliation: Memorial Sloan Kettering Cancer Center, Janssen (United States), University Hospital Heidelberg, Heidelberg University, National Center for Tumor Diseases, The Alfred Hospital, University of Alberta, Concord Hospital, Janssen (Belgium), Tisch Hospital, Amsterdam UMC Location VUmc, University of Bologna, Ankara University, Southampton General Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv University, Levine Cancer Institute, University of Nottingham, The Ohio State University, Georgia State University
Updated Results from the Phase 2 Centaurus Study of Daratumumab (DARA) Monotherapy in Patients with Intermediate-Risk or High-Risk Smoldering Multiple Myeloma (SMM)
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
